TGF-β1 is a canonical cytokine that promotes EMT and maintains the mesenchymal phenotype of cancer cells [17].Given the previous evidence that LXA4 can suppress many types of cytokines present during inflammatory responses [18], we inferred that LXA4 might down-regulate the level of TGF-β1. The gene discussed is TGFB1; the disease is cancer.